Australian Pharmaceutical Industries Ltd Income Statement Analysis
ASX:API
Health Care
•
Health Care Distributors
Income Statement
Comprehensive analysis of Australian Pharmaceutical Industries Ltd's revenue, expenses, and profitability
| Items | 2020 | 2021 | |
|---|---|---|---|
| Revenue | |||
| Total Revenue | 4.0B | 4.0B | |
| Costs and Expenses | |||
| Cost of Revenue | (3.5B) | (3.5B) | |
| Gross Profit | 474M | 495M | |
| Operating Expenses | (447M) | (561M) | |
| Operating Income | (2M) | 23M | |
| Other Income/Expenses | |||
| Interest Expense | (13M) | (10M) | |
| Profit Before Taxes | (15M) | 12M | |
| Income Tax | (7M) | 11M | |
| Net Income | (8M) | 1M | |
| Per Share Data | |||
| Basic EPS | (0.016) | 0.002 | |
| Diluted EPS | (0.016) | 0.002 | |
| Shares Outstanding (in millions) | |||
| Basic Shares | 493M | 493M | |
| Diluted Shares | 493M | 493M | |
Note: Fiscal year ends in August. All amounts are in AUD millions except per share data. Negative values are shown in parentheses and colored red. EPS values are shown to 3 decimal places, share counts are simplified (M = millions, B = billions).